Clinical effects of a Chinese herbal medicine on patients with chronic renal failure

This study assessed the impact of experienced prescription by Chinese medical master Zou Yanqin on chronic renal failure (CRF) patients. One hundred and twenty CRF patients admitted in Affiliated Hospital of Nanjing University of Chinese Medicine from January 2021 to December 2022 were randomly separated into a control group (CG) and a study group (SG). The CG accepted conventional therapy while the SG accepted treatment with Zou Yanqin prescription in addition to conventional treatment. The results showed that relative to CG, the SG had better total treatment effectiveness rate, lower serum creatinine as well as blood urea nitrogen levels, higher creatinine clearance rate, lower levels of inflammatory markers, higher serum albumin, hemoglobin and transferrin levels and lower incidence of adverse reactions. We conclude that experienced prescription by Chinese medical master Zou Yanqin can enhance the clinical treatment effect of conventional treatment, inhibit the inflammation, improve the nutritional status, and is safe for CRF patients.

Authors

Institutions

Publication Details

Journal
African Journal of Reproductive Health
Published
2025-05-17
DOI
https://doi.org/10.29063/ajrh2025/v29i5s.10
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical effects of a Chinese herbal medicine on patients with chronic renal failure

Xinyi Shen, Yanqin Zou, Hui Bu
African Journal of Reproductive Health
Chronic Kidney Disease and Diabetes
article

Clinical effects of a Chinese herbal medicine on patients with chronic renal failure

Xinyi Shen, Yanqin Zou, Hui Bu
article en

Abstract

This study assessed the impact of experienced prescription by Chinese medical master Zou Yanqin on chronic renal failure (CRF) patients. One hundred and twenty CRF patients admitted in Affiliated Hospital of Nanjing University of Chinese Medicine from January 2021 to December 2022 were randomly separated into a control group (CG) and a study group (SG). The CG accepted conventional therapy while the SG accepted treatment with Zou Yanqin prescription in addition to conventional treatment. The results showed that relative to CG, the SG had better total treatment effectiveness rate, lower serum creatinine as well as blood urea nitrogen levels, higher creatinine clearance rate, lower levels of inflammatory markers, higher serum albumin, hemoglobin and transferrin levels and lower incidence of adverse reactions. We conclude that experienced prescription by Chinese medical master Zou Yanqin can enhance the clinical treatment effect of conventional treatment, inhibit the inflammation, improve the nutritional status, and is safe for CRF patients.

African Journal of Reproductive HealthVol. 29(5s)
Nanjing University of Chinese Medicine (CN)
Zero hunger
Openalex Percentile: Top 87%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.